Insulet (PODD)
NASDAQ:PODD

Insulet (PODD) Stock Forecast & Price Target

482 Followers
See the Price Targets and Ratings of:

PODD Analyst Ratings

Moderate Buy
11Ratings
6 Buy
5 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Insulet
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PODD Stock 12 Months Forecast

Average Price Target

$297.55
▼(-3.41% Downside)
Based on 11 Wall Street analysts offering 12 month price targets for Insulet in the last 3 months. The average price target is $297.55 with a high forecast of $340.00 and a low forecast of $238.00. The average price target represents a -3.41% change from the last price of $308.06.
Highest Price Target$340.00Average Price Target$297.55Lowest Price Target$238.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Jefferies
$260.00
Hold
-15.60%
Downside
Initiated
Insulet initiated with a Hold at JefferiesInsulet initiated with a Hold at Jefferies
Cowen & Co.
$310.00
Buy
0.63%
Upside
Reiterated
Cowen reiterates Outperform on Insulet (PODD) on Omnipod 5 Label ExpansionCowen analyst Joshua Jennings reiterated an Outperform rating and $310.00 price target on Insulet Corporation (NASDAQ: PODD) after the company announced that Omnipod 5 received clearance from the FDA to be used in pediatric type 1 diabetic patients aged 2 and older.
Wells Fargo
$345.00
Buy
11.99%
Upside
Reiterated
Insulet price target lowered to $345 from $357 at Wells FargoInsulet price target lowered to $345 from $357 at Wells Fargo
SVB Securities
$280.00
Buy
-9.11%
Downside
Assigned
SVB Securities Reaffirms Their Buy Rating on Insulet (PODD)
Bank of America Securities
$300.00
Buy
-2.62%
Downside
Initiated
Insulet reinstated with a Buy at BofAInsulet reinstated with a Buy at BofA
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

PODD Financial Forecast

PODD Earnings Forecast
Next quarter’s earnings estimate for PODD is $0.21 with a range of $0.04 to $0.42. The previous quarter’s EPS was -$0.08. PODD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.42% of the time in the same period. In the last calendar year PODD has Underperformed its overall industry.
Next quarter’s earnings estimate for PODD is $0.21 with a range of $0.04 to $0.42. The previous quarter’s EPS was -$0.08. PODD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.42% of the time in the same period. In the last calendar year PODD has Underperformed its overall industry.
PODD Sales Forecast
Next quarter’s sales forecast for PODD is $332.48M with a range of $327.26M to $342.50M. The previous quarter’s sales results were $340.80M. PODD beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 42.88% of the time in the same period. In the last calendar year PODD has Outperformed its overall industry.
Next quarter’s sales forecast for PODD is $332.48M with a range of $327.26M to $342.50M. The previous quarter’s sales results were $340.80M. PODD beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 42.88% of the time in the same period. In the last calendar year PODD has Outperformed its overall industry.
PODD Analyst Recommendation Trends
In the current month, PODD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PODD average analyst price target in the past 3 months is $297.55
In the current month, PODD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PODD average analyst price target in the past 3 months is $297.55

PODD Stock Forecast FAQ

What is PODD’s average 12-month price target, according to analysts?
Based on analyst ratings, Insulet’s 12-month average price target is $297.55.
    What is PODD’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for PODD, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is PODD a Buy, Sell or Hold?
        Insulet has a conensus rating of Moderate Buy which is based on 6 buy ratings, 5 hold ratings and 0 sell ratings.
          What is Insulet’s price target?
          The average price target for Insulet is $297.55. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $340.00 ,the lowest forecast is $238.00. The average price target represents -3.41% Decrease from the current price of $308.06.
            What do analysts say about Insulet?
            Insulet’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis